» Articles » PMID: 12083336

Ischemic Cell Death: Dynamics of Delayed Secondary Energy Failure During Reperfusion Following Focal Ischemia

Overview
Journal Metab Brain Dis
Publisher Springer
Specialties Endocrinology
Neurology
Date 2002 Jun 27
PMID 12083336
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Reperfusion injury is believed to contribute to the pathophysiology of ischemic cell death, but the precipitating factors have yet to be completely elucidated. The goal of this study was to examine if reflow-induced secondary energy failure is a component in the events that lead to cell death following increasing periods of middle cerebral artery (MCA) occlusion in Wistar rats. Discrete sections within the MCA distribution were dissected and analyzed for high-energy phosphates and glucose. Regional cerebral blood flow was determined by [14C]-iodoantipyrine technique in representative groups. The levels of ATP + P-creatine were initially depressed at the end of the focal ischemia and the concentrations in the penumbra were unchanged for up to 8 h after 2 h of ischemia which contrasts with response in the ischemic core, striatum, and penumbra where the HEP generally recovered to values near those of control only to decrease with increasing periods of reflow. The possibility of a rebound ischemia in secondary energy failure (SEF) was precluded by regional CBF values and concentrations of glucose that were significantly higher than the threshold for an ischemic effect. The depletion of cellular energy stores following SEF strongly indicates that the evolution of infarct during reflow results from loss of ATP and its synthesis.

Citing Articles

Advanced rehabilitation in ischaemic stroke research.

Wang J, Li Y, Qi L, Mamtilahun M, Liu C, Liu Z Stroke Vasc Neurol. 2023; 9(4):328-343.

PMID: 37788912 PMC: 11420926. DOI: 10.1136/svn-2022-002285.


Metabolomic analysis and pharmacological validation of the cerebral protective effect of 3,4‑dihydroxybenzaldehyde on cerebral ischemia‑reperfusion injury.

Luo Y, Chen P, Yang L, Duan X Mol Med Rep. 2022; 27(1).

PMID: 36367170 PMC: 9685269. DOI: 10.3892/mmr.2022.12896.


Brain Energy Metabolism in Ischemic Stroke: Effects of Smoking and Diabetes.

Sifat A, Nozohouri S, Archie S, Chowdhury E, Abbruscato T Int J Mol Sci. 2022; 23(15).

PMID: 35955647 PMC: 9369264. DOI: 10.3390/ijms23158512.


Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons.

Li X, Li H, Xu Z, Ma C, Wang T, You W Cell Death Dis. 2022; 13(4):321.

PMID: 35395832 PMC: 8993832. DOI: 10.1038/s41419-022-04782-0.


Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.

Donner L, Feige T, Freiburg C, Toska L, Reichert A, Chatterjee M Int J Mol Sci. 2021; 22(17).

PMID: 34502546 PMC: 8431787. DOI: 10.3390/ijms22179633.


References
1.
van Uitert R, Levy D . Regional brain blood flow in the conscious gerbil. Stroke. 1978; 9(1):67-72. DOI: 10.1161/01.str.9.1.67. View

2.
Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

3.
Barrientos A, Moraes C . Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem. 1999; 274(23):16188-97. DOI: 10.1074/jbc.274.23.16188. View

4.
Lust W, Feussner G, Barbehenn E, Passonneau J . The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts. Anal Biochem. 1981; 110(2):258-66. DOI: 10.1016/0003-2697(81)90144-5. View

5.
Pulsinelli W, Waldman S, Rawlinson D, Plum F . Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982; 32(11):1239-46. DOI: 10.1212/wnl.32.11.1239. View